Lourens T. Bloem

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The platform technology approach in the EU regulation of medicines for human use: Stakeholder perspectives on its definition and implementation.

The platform technology approach in the EU regulation of medicines for human use: Stakeholder perspectives on its definition and implementation.

Journal: Drug discovery today

Published: February 06, 2026

Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review.

Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Shaping national networks to improve patient access to advanced therapy medicinal products in Europe.

Shaping national networks to improve patient access to advanced therapy medicinal products in Europe.

Journal: Drug discovery today

Published: December 22, 2025

Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands.

Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands.

Journal: Regenerative medicine

Published: December 01, 2025

Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligence.

Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligence.

Journal: JAMIA open

Published: October 21, 2025

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment.

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment.

Journal: British journal of clinical pharmacology

Published: May 19, 2025

A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications.

A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications.

Journal: Frontiers in medicine

Published: March 07, 2025

A Bayesian Approach to Compare Accumulating Survival Data From Clinical Practice With RCT Data: A Case Study in Non-Small Cell Lung Cancer Patients.

A Bayesian Approach to Compare Accumulating Survival Data From Clinical Practice With RCT Data: A Case Study in Non-Small Cell Lung Cancer Patients.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 16, 2024

Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group study.

Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group study.

Journal: BMJ open

Published: November 09, 2024

Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours.

Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours.

Journal: EBioMedicine

Published: November 07, 2024

Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?

Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?

Journal: Drug discovery today

Published: October 08, 2024

Development and Portability of a Text Mining Algorithm for Capturing Disease Progression in Electronic Health Records of Patients With Stage IV Non-Small Cell Lung Cancer.

Development and Portability of a Text Mining Algorithm for Capturing Disease Progression in Electronic Health Records of Patients With Stage IV Non-Small Cell Lung Cancer.

Journal: JCO clinical cancer informatics

Published: October 04, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026